News
Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs
-
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the launch of its ai² Future Labs program in partnership with The University of Alabama Culverhouse College of Business's STEM Path to the MBA program. The initiative aims to identify important assets critical to improving human health and to cultivate the next generation of pharmaceutical industry business leaders. Future Labs is part of Apimeds' ai² innovation platform, connectin.08/25/2025
Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division
-
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered, bee venom-based therapeutic, today announced two key additions to its executive leadership team. Susan Kramer, DrPH, has been appointed Senior Vice President of Development, and Brian Peters has joined as Head of the Company's proprietary ai²™ division. Dr. Kramer brings more than 30 year.07/15/2025
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions
Is Apimeds Pharmaceuticals US, Inc (APUS) a buy, sell, or hold?
Apimeds Pharmaceuticals US, Inc (APUS) can sell. Click on Rating Page for detail.
What is Apimeds Pharmaceuticals US, Inc's stock price?
The price of Apimeds Pharmaceuticals US, Inc (APUS) is 2.08 and it was updated on 2025-09-14 07:00:26.
Is Apimeds Pharmaceuticals US, Inc (APUS) overvalued or undervalued?
Currently Apimeds Pharmaceuticals US, Inc (APUS) is in undervalued.
News
| News |
|---|
 Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
|
 U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading
|
SEC Filings
Press Releases
| StockPrice Release |
|---|
APUS Ratings Summary
APUS Quant Ranking
